Section 516.28 - Publication of MUMS-drug designationsFDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Dockets Management Staff, and will contain the following information for each MUMS-designated drug:
(a) The name and address of the sponsor;(b) The established name and trade name, if any, of the drug;(c) The dosage form of the drug;(d) The species and the proposed intended use for which MUMS-drug designation was granted; and(e) The date designation was granted.72 FR 41017, July 26, 2007, as amended at 88 FR 45066, July 14, 2023 As amended at 88 FR 45066, 7/14/2023